iShares IV - iShares NASDAQ US Biotechnology UCITS ETF (BATS-CHIXE:BTECL) - Stock Price, News & Analysis

BTECL Stock Overview

An exchange traded fund launched by BlackRock Asset Management Ireland Limited.

BTECL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Competitors

Price History & Performance

Summary of all time highs, changes and price drops for iShares IV - iShares NASDAQ US Biotechnology UCITS ETF
Historical stock prices
Current Share Price	US$6.44
52 Week High	US$6.75
52 Week Low	US$5.40
Beta	0
1 Month Change	9.15%
3 Month Change	1.58%
1 Year Change	n/a
3 Year Change	-5.40%
5 Year Change	26.27%
Change since IPO	31.00%

Recent updates

Shareholder Returns

	BTECL	GB Capital Markets	GB Market
7D	1.3%	1.7%	0.5%
1Y	n/a	10.0%	6.3%

Return vs Industry: Insufficient data to determine how BTECL performed against the UK Capital Markets industry.

Return vs Market: Insufficient data to determine how BTECL performed against the UK Market.

Price Volatility

Is BTECL's price volatile compared to industry and market?
BTECL volatility
BTECL Average Weekly Movement	6.2%
Capital Markets Industry Average Movement	4.2%
Market Average Movement	4.9%
10% most volatile stocks in GB Market	11.1%
10% least volatile stocks in GB Market	2.7%

Stable Share Price: BTECL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BTECL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	n/a	www.ishares.com/uk/individual/en/products/291450/

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of the United States.

iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF Fundamentals Summary

How do iShares IV - iShares NASDAQ US Biotechnology UCITS ETF's earnings and revenue compare to its market cap?
BTECL fundamental statistics
Market cap	US$481.02m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is BTECL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BTECL income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did BTECL perform over the long term?

See historical performance and comparison

iShares IV - iShares NASDAQ US Biotechnology UCITS ETF BATS-CHIXE:BTECL Stock Report